Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway.
about
Chemical Variations on the p53 Reactivation ThemeTargeting Oncogenic Mutant p53 for Cancer TherapyTumor suppressor p53 and its gain-of-function mutants in cancerSmoking, p53 mutation, and lung cancerSmall molecule compounds targeting the p53 pathway: are we finally making progress?Structural evolution of p53, p63, and p73: Implication for heterotetramer formationStructural Basis for ASPP2 Recognition by the Tumor Suppressor p73The rebel angel: mutant p53 as the driving oncogene in breast cancer.JNK-NQO1 axis drives TAp73-mediated tumor suppression upon oxidative and proteasomal stressAciculatin induces p53-dependent apoptosis via MDM2 depletion in human cancer cells in vitro and in vivop73 as a pharmaceutical target for cancer therapyTargeting p53 for Novel Anticancer Therapy.Pathologies associated with the p53 response.Estrogen receptor beta decreases survival of p53-defective cancer cells after DNA damage by impairing G₂/M checkpoint signaling.Gain of cellular adaptation due to prolonged p53 impairment leads to functional switchover from p53 to p73 during DNA damage in acute myeloid leukemia cellsp53 Family and Cellular Stress Responses in Cancer.Targeting p53 by small molecules in hematological malignancies.p73 in Cancer.Translational approaches targeting the p53 pathway for anti-cancer therapy.Targeting the p53 signaling pathway in cancer therapy - the promises, challenges and perils.Prodigiosin rescues deficient p53 signaling and antitumor effects via upregulating p73 and disrupting its interaction with mutant p53.Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53.Mutant p53: one name, many proteins.Non-genotoxic anti-neoplastic effects of ellipticine derivative NSC176327 in p53-deficient human colon carcinoma cells involve stimulation of p73Therapeutic targeting of the p53 pathway in cancer stem cells.Therapeutic prospects for p73 and p63: rising from the shadow of p53.Pharmacological activation of p53 in cancer cellsTargeting the p53 pathway.Targeting cancer stem cells with p53 modulators.Benzyl Isothiocyanate potentiates p53 signaling and antitumor effects against breast cancer through activation of p53-LKB1 and p73-LKB1 axes.Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer.p53 family: Therapeutic targets in neuroblastoma.p53-based cancer therapyp53-targeted cancer pharmacotherapy: move towards small molecule compounds.The TP73 complex network: ready for clinical translation in cancer?The aggregation of mutant p53 produces prion-like properties in cancer.The clinical development of p53-reactivating drugs in sarcomas - charting future therapeutic approaches and understanding the clinical molecular toxicology of Nutlins.Mutant p53 in cancer: new functions and therapeutic opportunities.A balancing act: orchestrating amino-truncated and full-length p73 variants as decisive factors in cancer progression.Pharmacological reactivation of p53 as a strategy to treat cancer.
P2860
Q26749008-1A5667DC-F48C-4284-8A0F-E9874BA19D7CQ26770856-EBAAA85A-0205-46B5-85E3-08B5A5D14136Q27000754-B46A4D07-C084-40C6-B554-A9EA7F59629BQ27014977-B99A4F9D-7C5C-410B-9BA1-300D09FB26A7Q27027835-8CFF4B3A-0157-457E-B649-97083325611CQ27657730-49F3A06F-A3DD-435C-9153-4D2AB880D017Q27671671-7369CB2A-34D8-4202-9DD5-C7A19FAE0699Q27686765-830EA199-6E11-4257-99E3-9846A9D94450Q28394074-2511DE6A-1E44-4EA2-82E1-01EBCA7E20EDQ28482222-94F35261-7D4E-4A75-A3A6-5313AD673063Q28611414-FF390BE9-0656-4ACF-B04A-054BE8EF1E35Q33655329-D3AC8096-9B36-4B86-AED3-EF02867D0F46Q33931980-75E0437D-5384-4EC0-A45C-630B59740115Q34125558-9A5FAB33-8889-49F7-ACFD-1138246263F9Q34236709-2B796413-2961-4F55-8B3C-B5A16C0F8A21Q34377287-6836F410-4730-4823-9975-611A120DA209Q34636996-424DBF4B-4ADD-4BD1-967C-53293B4396AFQ35103143-6CF50FB8-7AB6-4087-A33A-B2F2ACC21FA7Q35708113-ADBFA536-E386-4465-A370-AAFCFBEDE0FEQ35795073-469F0B22-18F4-4B5F-BCB0-A6A478647405Q35951042-D0A89B8E-AB64-43E6-AE7B-D0C68788EF99Q36070528-2C12A053-9520-427F-BA1C-FF12EB244D93Q36070574-E6E3F337-DB6E-4F8C-8562-F4FA9E4F5D0AQ36766944-AB7ED4BE-E7D3-4B9E-92F5-A00B1113405BQ36833275-8E69D6B4-70F3-4F2E-A8A2-244AD8464E36Q36979908-504DFD2F-2759-48C2-9D5D-CC0464E1DE85Q37191174-156F418A-028F-4038-ACE4-472B77584C3CQ37260683-7FCF3FB5-9848-4CC9-BED7-E2F928741668Q37564349-D550EF59-D702-4E9A-84D2-C961CFD69E87Q37576027-B8512519-90A2-4044-A199-CE19A02CE90DQ37690890-F8195FF5-82E4-4268-B0E6-FB2946887361Q37707387-B9B2DA7A-A422-401C-83C0-0DE17E874841Q37750115-3B62525F-6AE1-4CC9-B583-3FDB5C00564EQ37865050-E5870EDC-EDFE-4238-8667-EACBF91FB3A2Q38126476-BC56B8B3-9ECA-4DF1-B268-D61E37932D92Q38186535-9F274020-69C7-4D21-8F78-3C27ECBB63F4Q38192005-6263DF0A-B6B2-4643-8985-12E497ACE6ACQ38197826-80AD0B17-346E-4EE3-8277-4CCCC4EC66DCQ38266299-8AAF7453-65F3-479A-BE49-F7DE9C810C38Q38286198-312C346F-57BF-4E3E-872B-8C76C8EE648E
P2860
Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway.
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Small-molecule RETRA suppresse ...... p73-dependent salvage pathway.
@ast
Small-molecule RETRA suppresse ...... p73-dependent salvage pathway.
@en
Small-molecule RETRA suppresse ...... p73-dependent salvage pathway.
@nl
type
label
Small-molecule RETRA suppresse ...... p73-dependent salvage pathway.
@ast
Small-molecule RETRA suppresse ...... p73-dependent salvage pathway.
@en
Small-molecule RETRA suppresse ...... p73-dependent salvage pathway.
@nl
prefLabel
Small-molecule RETRA suppresse ...... p73-dependent salvage pathway.
@ast
Small-molecule RETRA suppresse ...... p73-dependent salvage pathway.
@en
Small-molecule RETRA suppresse ...... p73-dependent salvage pathway.
@nl
P2093
P2860
P356
P1476
Small-molecule RETRA suppresse ...... p73-dependent salvage pathway
@en
P2093
A V Gudkov
D V Kochetkov
E Feinstein
E I Frolova
G V Ilyinskaya
J E Kravchenko
L S Agapova
P G Komarov
P2860
P304
P356
10.1073/PNAS.0802091105
P407
P577
2008-04-18T00:00:00Z